1242137-18-3: Enzalutamide Oxo Impurity

Enzalutamide Oxo Impurity (CAS No.1242137-18-3) or 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide. Enzalutamide is a nonsteroidal antiandrogen that binds to the ligand-binding domain and has more affinity. It is used in the treatment of castration-resistant prostate cancer.

Additional information

Catalogue No.

VE006364

CAS No.

1242137-18-3

Molecular Formula

C21H16F4N4O3

Molecular Weight

448.37

IUPAC Name

4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5, 5-dimethyl-2, 4-dioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide

References

"Schrader, Andres Jan, et al. “Enzalutamide in Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel and Abiraterone.” European Urology, vol. 65, no. 1, Jan. 2014, pp. 30–36, https://doi.org/10.1016/j.eururo.2013.06.042. ?Graff, Julie N., et al. “Early Evidence of Anti-PD-1 Activity in Enzalutamide-Resistant Prostate Cancer.” Oncotarget, vol. 7, no. 33, July 2016, pp. 52810–17, https://doi.org/10.18632/oncotarget.10547. ?"

Status

In-stock